GLP-1 Coverage & Costs in Massachusetts (2026)

Massachusetts Medicaid Coverage for GLP-1

Massachusetts Medicaid GLP-1 Prescriptions in 2025

Massachusetts Medicaid paid for 399,014 GLP-1 prescriptions in 2025, 3.5% of the 11.26 million paid nationally and number 7 of 51 (50 states and DC). It reimbursed pharmacies $396.7 million before manufacturer rebates, about $994 per prescription, and the most-filled product was Zepbound. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 217,397 of those prescriptions (54.5%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.

From 2021 to 2025, Massachusetts Medicaid GLP-1 prescriptions went from 85,587 to 399,014, 4.7 times the 2021 count. From 2024 to 2025 the count rose by 144,524.

Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.

Massachusetts Employee Plan and Insurer GLP-1 Rules

We have no Massachusettsinsurer policy on record yet. Most commercial plans decide GLP-1 coverage plan by plan, so the employer's choice matters as much as the insurer.

Telehealth Programs to Check for Massachusetts

We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Massachusetts. The rest record a state count without naming the states, so confirm Massachusetts with the program at intake before you pay.

What Programs' Own Pages Say About Massachusetts

8 of the 8 programs whose own pages name the states they serve include Massachusetts: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.

Trimi's state table lists Massachusetts as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for Massachusetts is Mass. Gen. Laws ch. 112, § 5O (see also Board of Registration in Medicine Policy 2020-01). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.

Programs on Our List, in Published Order

45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.

Estimated GLP-1 Costs in Massachusetts

The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.

Medicare Part D GLP-1 Claims in Massachusetts, 2024

Massachusetts prescribers wrote 525,777 Medicare Part D GLP-1 claims in 2024, number 13 of 51, with $645.8 million in gross drug cost before rebates. Ozempic led with 199,467 claims for 36,878 enrollees. Wegovy had 11,826 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.

Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.

How Massachusetts Compares to Other Northeast States

Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Massachusetts and its neighbors in the Northeast are recorded:

Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.

KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.

How to Check Your Specific Plan in Massachusetts

Frequently Asked Questions — Massachusetts